Question 1

What are the expected benefits of cetuximab for my specific situation?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

Question 2

How does cetuximab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking cetuximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I know about the logistics of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer clinical trial (NCT00207155). Contact the study team or your healthcare provider for specific answers.

What this study is about